Retaglutide is a innovative GLP-1 receptor agonist currently under investigation for the control of type 2 diabetes. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://lilliuvwp947761.blogrelation.com/45494173/retaglutide-a-promising-glp-1-receptor-agonist